ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced that ProQR management will host an investor conference call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently announced partnership expansion with Lilly. ProQR will host the call on December 22, 2022, at 8:15am EST.
Related news for (PRQR)
- MoBot alert highlights: NASDAQ: AKAN, NASDAQ: KZR, NASDAQ: ARTV, NASDAQ: QCLS, NASDAQ: PRQR (10/16/25 04:00 PM)
- ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
- ProQR to Present at Upcoming Scientific and Industry Conferences
- Lilly and ProQR to Expand RNA Editing Collaboration
